Imiquimod and the treatment of cutaneous T-cell proliferative diseases: at the threshold.
作者信息
Herbert W Clark
机构信息
Department of Dermatology, The University of Medicine & Dentistry of New Jersey-New Jersey Medical School, Newark, NJ 07103, USA.
出版信息
Skinmed. 2003 Sep-Oct;2(5):273-4. doi: 10.1111/j.1540-9740.2003.02470.x.
Abstract
摘要
相似文献
1
Imiquimod and the treatment of cutaneous T-cell proliferative diseases: at the threshold.咪喹莫特与皮肤T细胞增殖性疾病的治疗：处于临界状态。
Skinmed. 2003 Sep-Oct;2(5):273-4. doi: 10.1111/j.1540-9740.2003.02470.x.
2
Topical imiquimod therapy for cutaneous T-cell lymphoma.咪喹莫特局部治疗皮肤T细胞淋巴瘤
Skinmed. 2003 Sep-Oct;2(5):316-8. doi: 10.1111/j.1540-9740.2003.02258.x.
3
Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Br J Dermatol. 2007 Sep;157(3):620-2. doi: 10.1111/j.1365-2133.2007.07976.x. Epub 2007 Jun 6.
4
Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.采用免疫反应调节剂咪喹莫特局部应用治疗IA期皮肤T细胞淋巴瘤。
Arch Dermatol. 2002 Sep;138(9):1137-9. doi: 10.1001/archderm.138.9.1137.
5
Interferon in the treatment of cutaneous T-cell lymphoma.干扰素治疗皮肤T细胞淋巴瘤。
Dermatol Ther. 2003;16(4):311-21. doi: 10.1111/j.1396-0296.2003.01643.x.
6
Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).对局部用咪喹莫特（艾拉）有反应的原发性皮肤CD30 + T细胞淋巴瘤
Br J Dermatol. 2004 Jun;150(6):1198-201. doi: 10.1111/j.1365-2133.2004.05993.x.
7
Topical imiquimod as treatment for different kinds of cutaneous lymphoma.外用咪喹莫特治疗不同类型的皮肤淋巴瘤。
Eur J Dermatol. 2006 Jul-Aug;16(4):391-3.
8
Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial.APO866用于难治性或复发性皮肤T细胞淋巴瘤患者的疗效与安全性：一项2期临床试验
JAMA Dermatol. 2016 Jul 1;152(7):837-9. doi: 10.1001/jamadermatol.2016.0401.
9
Infantile hemangioma: clinical resolution with 5% imiquimod cream.婴儿血管瘤：5%咪喹莫特乳膏治疗的临床消退情况
Arch Dermatol. 2002 Jul;138(7):881-4; discussion 884. doi: 10.1001/archderm.138.7.881.
10
Imiquimod for the treatment of skin cancer.咪喹莫特用于治疗皮肤癌。
Dermatol Clin. 2005 Jan;23(1):151-64, vii. doi: 10.1016/j.det.2004.08.007.
引用本文的文献
1
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.肿瘤微环境在恶性条件下的免疫调节过程。
Int J Mol Sci. 2021 Dec 10;22(24):13311. doi: 10.3390/ijms222413311.
Zotero 插件